Merve Usta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Merve Usta has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Nafiye Urgancı
Department of Pediatrics, Division of Pediatric Gastroenterology University of Health Sciences, Şişli Hamidiye Etfal Training and Research Hospital Istanbul Türkiye
8 shared publications - Dilek Güller
Department of Pediatric Gastroenterology and Hepatology, Prof. Dr. Cemil Tascioglu City Hospital, University of Health Sciences, Istanbul 34384, Turkey
2 shared publications - Alev Kural
Department of Clinical Chemistry, Department of Biochemistry University of Health Sciences, Bakirköy Dr. Sadi Konuk Training and Research Hospital İstanbul Türkiye
1 shared publication - Anil Akkus
Department of Biochemistry, University of Health Sciences, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey
1 shared publication - Aybike Koç
Department of Pediatrics, Division of Pediatric Hematology and Oncology, Sisli Hamidiye Etfal Training and Research Hospital, University of Health Sciences, Istanbul, Türkiye
1 shared publication - Aysen Yarat
Marmara University
1 shared publication
Latest Publications
- 17 November 2026
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
Serum serotonin levels in children with functional constipation: A prospective case‐control study
Objective: Functional constipation is a common pediatric functional gastrointestinal disorder, but data on circulating serotonin are limited. This study compared fasting serum serotonin levels between children with functional constipation and healthy controls and examined associations with clinical characteristics. Methods: This prospective, single‐center, case–control study included children aged 4–18 years with Rome IV‐defined functional constipation and healthy controls. Fasting serum serotonin was measured using enzyme‐linked immunosorbent assay. Clinical characteristics, including fecal incontinence, body mass index categories, and treatment response, were evaluated. Receiver operating characteristic analysis assessed discriminatory performance. Results: Seventy‐four children were included: 37 with functional constipation and 37 controls. Age and sex distribution were similar. Serum serotonin levels were higher in children with functional constipation (174.1 ng/mL [interquartile range, IQR, 161.1–188.3] versus 160.5 ng/mL [IQR, 149.5–181.9]; p = 0.048). Children with fecal incontinence had higher serum serotonin levels in the unadjusted analysis ( p = 0.031), but this finding did not remain significant after correction for multiple comparisons. After excluding children with fecal incontinence, the between‐group difference was no longer significant ( p = 0.134). Levels were numerically higher in children with obesity, but differences across body mass index categories were not significant. The area under the receiver operating characteristic curve was 0.628 (95% confidence interval, 0.496–0.759; p = 0.062). Conclusions: Serum serotonin was modestly higher in children with functional constipation, but diagnostic utility was limited. These exploratory findings do not support its use as a diagnostic marker. Further studies are needed to clarify serotonin‐related pathways in pediatric functional constipation.
- 17 November 2026
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
Serum serotonin levels in children with functional constipation: A prospective case‐control study
Objective: Functional constipation is a common pediatric functional gastrointestinal disorder, but data on circulating serotonin are limited. This study compared fasting serum serotonin levels between children with functional constipation and healthy controls and examined associations with clinical characteristics. Methods: This prospective, single‐center, case–control study included children aged 4–18 years with Rome IV‐defined functional constipation and healthy controls. Fasting serum serotonin was measured using enzyme‐linked immunosorbent assay. Clinical characteristics, including fecal incontinence, body mass index categories, and treatment response, were evaluated. Receiver operating characteristic analysis assessed discriminatory performance. Results: Seventy‐four children were included: 37 with functional constipation and 37 controls. Age and sex distribution were similar. Serum serotonin levels were higher in children with functional constipation (174.1 ng/mL [interquartile range, IQR, 161.1–188.3] versus 160.5 ng/mL [IQR, 149.5–181.9]; p = 0.048). Children with fecal incontinence had higher serum serotonin levels in the unadjusted analysis ( p = 0.031), but this finding did not remain significant after correction for multiple comparisons. After excluding children with fecal incontinence, the between‐group difference was no longer significant ( p = 0.134). Levels were numerically higher in children with obesity, but differences across body mass index categories were not significant. The area under the receiver operating characteristic curve was 0.628 (95% confidence interval, 0.496–0.759; p = 0.062). Conclusions: Serum serotonin was modestly higher in children with functional constipation, but diagnostic utility was limited. These exploratory findings do not support its use as a diagnostic marker. Further studies are needed to clarify serotonin‐related pathways in pediatric functional constipation.
- Open Access
- 28 July 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Evaluation of claudin-2, claudin-3 and claudin-4 proteins in children with inflammatory bowel diseases
- 28 July 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessEvaluation of claudin-2, claudin-3 and claudin-4 proteins in children with inflammatory bowel diseases
- 8 January 2026
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 65 (4) , 473-480
Assessment of Functional Gastrointestinal Disorders in Children With Asthma
The aim of the study was to evaluate prevalence of functional gastrointestinal disorders (FGID) in children with asthma and to determine the relationship between FGID and asthma control and anxiety. Two hundred fifty children aged 6 to 18 years with asthma were enrolled in this single-center study. The FGID screening questionnaire, an asthma control test, and the Revised Children’s Anxiety and Depression Scale (RCADS) were applied to the patients. A significant difference was observed only in the rate of anxiety in children with FGID in the 6 to 11 age group. The incidence of FGID in girls was found to be higher than that in boys in the 12 to 18 age group ( P = .015). While a statistically significant difference was found between FGID and asthma control in cases between the ages of 12 to 18 ( P = .001), no difference was observed in the 6 to 11 age group. The prevalence of FGID is high in children with asthma, especially in adolescence.
- 8 January 2026
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 65 (4) , 473-480
Assessment of Functional Gastrointestinal Disorders in Children With Asthma
The aim of the study was to evaluate prevalence of functional gastrointestinal disorders (FGID) in children with asthma and to determine the relationship between FGID and asthma control and anxiety. Two hundred fifty children aged 6 to 18 years with asthma were enrolled in this single-center study. The FGID screening questionnaire, an asthma control test, and the Revised Children’s Anxiety and Depression Scale (RCADS) were applied to the patients. A significant difference was observed only in the rate of anxiety in children with FGID in the 6 to 11 age group. The incidence of FGID in girls was found to be higher than that in boys in the 12 to 18 age group ( P = .015). While a statistically significant difference was found between FGID and asthma control in cases between the ages of 12 to 18 ( P = .001), no difference was observed in the 6 to 11 age group. The prevalence of FGID is high in children with asthma, especially in adolescence.
- Open Access
- 22 December 2025
- Published by Springer Nature in BMC Pediatrics
- Vol. 26 (1)
Association of endocrine autoantibodies (anti-TPO, anti-GAD, anti-insulin) with histopathological severity in pediatric Celiac disease: a retrospective cohort study
Celiac disease (CD) is an autoimmune disorder triggered by gluten ingestion, characterized by the development of specific autoantibodies. An increased inci
- 22 December 2025
- Published by Springer Nature in BMC Pediatrics
- Vol. 26 (1)
Open AccessAssociation of endocrine autoantibodies (anti-TPO, anti-GAD, anti-insulin) with histopathological severity in pediatric Celiac disease: a retrospective cohort study
Celiac disease (CD) is an autoimmune disorder triggered by gluten ingestion, characterized by the development of specific autoantibodies. An increased inci
- 18 October 2025
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 184 (11) , 1-11
Evaluation of anemia at diagnosis and during follow-up in childhood inflammatory bowel diseases
The aim of this study is to evaluate anemia in children with inflammatory bowel diseases (IBD), both at the time of diagnosis and over a 1-year follow-up period. A total of 160 children with IBD were included in this retrospective study. Demographic, clinical characteristics, laboratory parameters, and treatment modalities were evaluated. Etiologies of anemia were determined. The mean age of the patients was 154.9 ± 39.6 months and M/F:1.1. Then, 61.9% of the patients at diagnosis and 25.9% at follow-up had anemia. The most common cause of anemia was iron defiency anemia (IDA) at diagnosis and follow-up (58.7% vs. 25.9%). Further, 80.6% of the patients had iron deficiency which decreased to 71.6% at follow-up. Anemia of chronic disease was determined in 54.4% of the patients at diagnosis, and in 12.9% at follow-up. Vitamin B12 deficiency was observed in 21.3% of the patients and vitamin B12 anemia in 11.9% of those patients at diagnosis, but these rates decreased to 9.5% and 1.7%, respectively during follow-up. Folic acid deficiency was 13.8% and folic acid anemia was 8.8% at diagnosis, but these rates decreased to 4.3% and 1.7%, respectively during follow-up. Anemia was more common in patients with moderate and severe disease than those with mild disease. Conclusion: Anemia is highly prevalent in pediatric IBD, particularly at diagnosis, and may persist despite treatment in a considerable number of patients. Regular screening and etiology-specific management are essential for optimizing growth and long-term outcomes. Prospective multicenter studies are needed to establish standardized anemia monitoring and treatment protocols in pediatric IBD. What is Known: • Anemia is one of the most common extraintestinal manifestations in inflammatory bowel disease (IBD). • The most common type of anemia in patients with IBD are iron deficiency anemia and anemia of chronic disease. What is New: • This is one of the few pediatric IBD studies to longitudinally evaluate anemia subtypes (iron deficiency, anemia of chronic disease, vitamin B12, and folate) at both diagnosis and 1-year follow-up. • We show that more than half of patients had mixed anemia etiologies at diagnosis, highlighting the multifactorial pathophysiology of anemia in IBD. One-third of children remained anemic after 1 year, despite treatment, underscoring the need for standardized monitoring and tailored interventions in pediatric IBD care.
- 18 October 2025
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 184 (11) , 1-11
Evaluation of anemia at diagnosis and during follow-up in childhood inflammatory bowel diseases
The aim of this study is to evaluate anemia in children with inflammatory bowel diseases (IBD), both at the time of diagnosis and over a 1-year follow-up period. A total of 160 children with IBD were included in this retrospective study. Demographic, clinical characteristics, laboratory parameters, and treatment modalities were evaluated. Etiologies of anemia were determined. The mean age of the patients was 154.9 ± 39.6 months and M/F:1.1. Then, 61.9% of the patients at diagnosis and 25.9% at follow-up had anemia. The most common cause of anemia was iron defiency anemia (IDA) at diagnosis and follow-up (58.7% vs. 25.9%). Further, 80.6% of the patients had iron deficiency which decreased to 71.6% at follow-up. Anemia of chronic disease was determined in 54.4% of the patients at diagnosis, and in 12.9% at follow-up. Vitamin B12 deficiency was observed in 21.3% of the patients and vitamin B12 anemia in 11.9% of those patients at diagnosis, but these rates decreased to 9.5% and 1.7%, respectively during follow-up. Folic acid deficiency was 13.8% and folic acid anemia was 8.8% at diagnosis, but these rates decreased to 4.3% and 1.7%, respectively during follow-up. Anemia was more common in patients with moderate and severe disease than those with mild disease. Conclusion: Anemia is highly prevalent in pediatric IBD, particularly at diagnosis, and may persist despite treatment in a considerable number of patients. Regular screening and etiology-specific management are essential for optimizing growth and long-term outcomes. Prospective multicenter studies are needed to establish standardized anemia monitoring and treatment protocols in pediatric IBD. What is Known: • Anemia is one of the most common extraintestinal manifestations in inflammatory bowel disease (IBD). • The most common type of anemia in patients with IBD are iron deficiency anemia and anemia of chronic disease. What is New: • This is one of the few pediatric IBD studies to longitudinally evaluate anemia subtypes (iron deficiency, anemia of chronic disease, vitamin B12, and folate) at both diagnosis and 1-year follow-up. • We show that more than half of patients had mixed anemia etiologies at diagnosis, highlighting the multifactorial pathophysiology of anemia in IBD. One-third of children remained anemic after 1 year, despite treatment, underscoring the need for standardized monitoring and tailored interventions in pediatric IBD care.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista de Nutrição
- Vol. 37, e230013
Nutritional assessment of the children in pediatric intensive care unit with subjective global nutritional assessment and its relationship with the prognosis
Objective This study aims to evaluate the nutritional status of patients hospitalized in pediatric intensive care unit with Subjective Global Nutritional Assessment and its relationship with prognosis.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista de Nutrição
- Vol. 37, e230013
Open AccessNutritional assessment of the children in pediatric intensive care unit with subjective global nutritional assessment and its relationship with the prognosis
Objective This study aims to evaluate the nutritional status of patients hospitalized in pediatric intensive care unit with Subjective Global Nutritional Assessment and its relationship with prognosis.
- 1 June 2022
- Published by Galenos Yayinevi in Cyprus Journal of Medical Sciences
- Vol. 7 (3) , 349-353
Prevalence of Helicobacter pylori Infection in Pediatric Patients With Celiac Disease
- 1 June 2022
- Published by Galenos Yayinevi in Cyprus Journal of Medical Sciences
- Vol. 7 (3) , 349-353
Prevalence of Helicobacter pylori Infection in Pediatric Patients With Celiac Disease
- Open Access
- 1 September 2018
- Published by Istanbul University in İstanbul Tıp Fakültesi Dergisi
- Vol. 52 (3) , 150-156
Clinical evaluation of dental enamel defects and oral findings in coeliac children
İstanbul Üniversitesi | Tarihten Geleceğe Bilim Köprüsü - 1453
- 1 September 2018
- Published by Istanbul University in İstanbul Tıp Fakültesi Dergisi
- Vol. 52 (3) , 150-156
Open AccessClinical evaluation of dental enamel defects and oral findings in coeliac children
İstanbul Üniversitesi | Tarihten Geleceğe Bilim Köprüsü - 1453
- 1 June 2014
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 133 (6) , e1518-e1524
High Doses of Methylprednisolone in the Management of Caustic Esophageal Burns
OBJECTIVE: Caustic substance ingestion in childhood is a public health issue in developing countries, and several management protocols have been proposed to prevent the resulting esophageal strictures. The role of corticosteroids in preventing corrosive-induced strictures is controversial. Our aim was to study the influence of high doses of corticosteroids in preventing esophageal strictures. METHODS: Eighty-three children with a mean age of 4.10 ± 2.63 years and with grade IIb esophageal burns (an esophagogastroscopy was performed within 24–48 hours of injury) due to corrosive substance ingestion were enrolled in our study between 2005 and 2008. Forty-two children (study group) received methylprednisolone (1 g/1.73 m2 per day for 3 days), ranitidine, ceftriaxone, and total parenteral nutrition. Forty-one children (control group) were administered the same regimen excluding methylprednisolone. Stricture development was compared between groups based on endoscopic and radiologic findings. RESULTS: During the endoscopic examination, stricture development was observed in 4 patients (10.8%) in the study group and in 12 patients (30%) in the control group. The difference was statistically significant (P = .038). The stricture development rate in the upper gastrointestinal system with barium meal was 14.3% and 45.0% in the study and control groups, respectively. The difference was statistically significant (P = .004). The duration of total parenteral nutrition was shorter in the study group compared with the control group (P = .001). High doses of methylprednisolone were well tolerated in the study group without any side effects. CONCLUSIONS: High doses of methylprednisolone used for the management of grade IIb esophageal burns may reduce stricture development.
- 1 June 2014
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 133 (6) , e1518-e1524
High Doses of Methylprednisolone in the Management of Caustic Esophageal Burns
OBJECTIVE: Caustic substance ingestion in childhood is a public health issue in developing countries, and several management protocols have been proposed to prevent the resulting esophageal strictures. The role of corticosteroids in preventing corrosive-induced strictures is controversial. Our aim was to study the influence of high doses of corticosteroids in preventing esophageal strictures. METHODS: Eighty-three children with a mean age of 4.10 ± 2.63 years and with grade IIb esophageal burns (an esophagogastroscopy was performed within 24–48 hours of injury) due to corrosive substance ingestion were enrolled in our study between 2005 and 2008. Forty-two children (study group) received methylprednisolone (1 g/1.73 m2 per day for 3 days), ranitidine, ceftriaxone, and total parenteral nutrition. Forty-one children (control group) were administered the same regimen excluding methylprednisolone. Stricture development was compared between groups based on endoscopic and radiologic findings. RESULTS: During the endoscopic examination, stricture development was observed in 4 patients (10.8%) in the study group and in 12 patients (30%) in the control group. The difference was statistically significant (P = .038). The stricture development rate in the upper gastrointestinal system with barium meal was 14.3% and 45.0% in the study and control groups, respectively. The difference was statistically significant (P = .004). The duration of total parenteral nutrition was shorter in the study group compared with the control group (P = .001). High doses of methylprednisolone were well tolerated in the study group without any side effects. CONCLUSIONS: High doses of methylprednisolone used for the management of grade IIb esophageal burns may reduce stricture development.